A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?

[1]  M. Friedrich-Rust,et al.  Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  A. Zell,et al.  Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver , 2013, Diabetes Care.

[3]  S. Daskalopoulou,et al.  Carotid endarterectomy improves peripheral but not central arterial stiffness. , 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  A. Folsom,et al.  Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis). , 2013, The American journal of cardiology.

[5]  M. Ermani,et al.  Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[6]  M. Budoff,et al.  Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. , 2013, Atherosclerosis.

[7]  N. Stefan,et al.  The role of hepatokines in metabolism , 2013, Nature Reviews Endocrinology.

[8]  Perspective: nonalcoholic fatty liver disease and cardiovascular risk. , 2013, Current opinion in lipidology.

[9]  Y. Yılmaz,et al.  Assessment of endothelial function in patients with nonalcoholic fatty liver disease , 2013, Endocrine.

[10]  S. Wild,et al.  Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome , 2012, Diabetes Care.

[11]  B. Kim,et al.  The Association between Nonalcoholic Fatty Liver Disease, Metabolic Syndrome and Arterial Stiffness in Nondiabetic, Nonhypertensive Individuals , 2012, Cardiology.

[12]  Jin Hwa Kang,et al.  Nonalcoholic fatty liver disease is associated with coronary artery calcification , 2012, Hepatology.

[13]  R. Pandey,et al.  Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. , 2012, Atherosclerosis.

[14]  N. Curzen,et al.  Nonalcoholic fatty liver disease and vascular risk , 2012, Current opinion in cardiology.

[15]  G. Kocabay,et al.  Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease , 2012, European journal of gastroenterology & hepatology.

[16]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[17]  Christopher D Byrne,et al.  Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? , 2012, European heart journal.

[18]  Yu Xu,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[19]  S. Bağcı,et al.  Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? , 2012, Diabetes research and clinical practice.

[20]  A. Sanyal,et al.  Lipotoxicity in NASH. , 2012, Journal of hepatology.

[21]  A. Mohammadi,et al.  Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease , 2011, Vascular health and risk management.

[22]  DeMarc Hickson,et al.  Fatty Liver, Abdominal Visceral Fat, and Cardiometabolic Risk Factors: The Jackson Heart Study , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. Mohammadi,et al.  Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease , 2011, International journal of general medicine.

[24]  D. Burns,et al.  Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. , 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[25]  N. Stefan,et al.  The Metabolically Benign and Malignant Fatty Liver , 2011, Diabetes.

[26]  G. Sesti,et al.  Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[27]  R. Blumenthal,et al.  Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[28]  J. Shim,et al.  Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification , 2010, Clinical chemistry and laboratory medicine.

[29]  C. Vlachopoulos,et al.  Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study. , 2010, American journal of hypertension.

[30]  E. Bonora,et al.  Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. , 2010, Journal of hepatology.

[31]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[32]  A. Benetos,et al.  Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study , 2010, Journal of hypertension.

[33]  Chris Day,et al.  A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.

[34]  C. Vlachopoulos,et al.  Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness , 2011 .

[35]  R. Farah,et al.  Presence of coronary plaques in patients with nonalcoholic fatty liver disease. , 2010, Radiology.

[36]  Michael E. Cobble,et al.  Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice , 2010, Postgraduate medicine.

[37]  M. Yalçın,et al.  Abnormal aortic elasticity in patients with liver steatosis. , 2010, Diabetes research and clinical practice.

[38]  Chien-Hua Chen,et al.  Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification , 2010, Digestive Diseases and Sciences.

[39]  N. Stefan,et al.  High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. , 2009, Atherosclerosis.

[40]  J. Cercueil,et al.  Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. , 2009, The Journal of clinical endocrinology and metabolism.

[41]  Jin Hwa Kang,et al.  The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans , 2009, The American Journal of Gastroenterology.

[42]  D. Kim,et al.  Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. , 2009, Atherosclerosis.

[43]  Fang-Chi Hsu,et al.  Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart Study , 2008, The American Journal of Gastroenterology.

[44]  J. J. Rivera,et al.  Markers of inflammation and coronary artery calcification: a systematic review. , 2008, Atherosclerosis.

[45]  S. Sookoian,et al.  Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. , 2008, Journal of hepatology.

[46]  G. Marchesini,et al.  Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? , 2008, Diabetologia.

[47]  Fritz Schick,et al.  Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.

[48]  J. Féher,et al.  [Non-alcoholic fatty liver disease and cardiovascular risk]. , 2008, Orvosi hetilap.

[49]  M. Diamant,et al.  Endothelial dysfunction in Turkish patients with non‐alcoholic fatty liver disease , 2008, Internal medicine journal.

[50]  O. Kocaman,et al.  Endothelial dysfunction in Turkish patients with non‐alcoholic fatty liver disease , 2008, Internal medicine journal.

[51]  J. Borén,et al.  Fatty liver, insulin resistance, and dyslipidemia , 2008, Current diabetes reports.

[52]  Norbert Stefan,et al.  Causes and metabolic consequences of Fatty liver. , 2008, Endocrine reviews.

[53]  L. N. Valenti,et al.  Carotid artery intima-media thickness in nonalcoholic fatty liver disease. , 2008, The American journal of medicine.

[54]  T. Yoshikawa,et al.  Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[55]  O. Kocaman,et al.  Evaluation of Metabolic Syndrome Frequency and Carotid Artery Intima-media Thickness as Risk Factors for Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease , 2008, Digestive Diseases and Sciences.

[56]  Poonam Mishra,et al.  Abdominal Ultrasound for Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) , 2007, The American Journal of Gastroenterology.

[57]  R. Blumenthal,et al.  Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men. , 2007, Atherosclerosis.

[58]  Manisha Talim,et al.  Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients , 2007, Diabetes Care.

[59]  G. Targher,et al.  Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. , 2007, Atherosclerosis.

[60]  G. Targher.  Non‐alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[61]  A. McCullough.  Pathophysiology of nonalcoholic steatohepatitis. , 2006, Journal of clinical gastroenterology.

[62]  K. Ferdinand.  Coronary artery disease in minority racial and ethnic groups in the United States. , 2006, The American journal of cardiology.

[63]  Federica Agostini,et al.  Nonalcoholic fatty liver disease and the metabolic syndrome , 2005, Current opinion in lipidology.

[64]  B. Neuschwander‐Tetri.  Nonalcoholic steatohepatitis and the metabolic syndrome. , 2005, The American journal of the medical sciences.

[65]  G. Targher,et al.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.

[66]  L. Adams,et al.  Recent concepts in non‐alcoholic fatty liver disease , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[67]  G. Marchesini,et al.  Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease , 2005, Hepatology.

[68]  Emilio Ros,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[69]  U. John,et al.  Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. , 2005, World journal of gastroenterology.

[70]  Ali H. Mokdad,et al.  State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.

[71]  S. Grundy,et al.  The metabolic syndrome , 2003, The Lancet.

[72]  E. Sondik,et al.  Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke--United States, 2003. , 2005, MMWR. Morbidity and mortality weekly report.

[73]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[74]  C. Ahn,et al.  Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. , 2004, Archives of internal medicine.

[75]  G. Zoppini,et al.  Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. , 2004, Diabetes care.

[76]  A. McCullough,et al.  The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[77]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[78]  J. Everhart,et al.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.

[79]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[80]  G. Pacini,et al.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.

[81]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[82]  R. Detrano,et al.  Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. , 2000, The American journal of cardiology.

[83]  L. Weinehall,et al.  High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. , 1998, Circulation.

[84]  W. Edwards,et al.  Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. , 1998, Journal of the American College of Cardiology.

[85]  Y. Arad,et al.  Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. , 1996, Circulation.

[86]  E. Zeitler,et al.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.